Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
July 14, 2022 16:56 ET
|
Zymergen Inc.
EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
June 28, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to 3D4Makers...
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform
May 26, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular automation...
Zymergen Reports Preliminary First Quarter 2022 Financial Results
May 12, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended March...
Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
April 29, 2022 08:00 ET
|
Zymergen Inc.
EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare...
Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022
April 13, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after...
Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 22, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and full...
Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022
March 16, 2022 16:05 ET
|
Zymergen Inc.
EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the fourth quarter and full year...
Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing
March 06, 2022 19:00 ET
|
Zymergen Inc.
EMERYVILLE, Calif., March 06, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) is pleased to announce early results from its work on infectious disease, discovering hundreds of potential...
Zymergen to Present at the 42nd Annual Cowen Healthcare Conference
February 28, 2022 08:00 ET
|
Zymergen Inc.
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming 42nd Annual Cowen Virtual...